Aller au contenu
Black Friday — 30% OFFLivraison gratuite dès 99 € d’achat
  1. Accueil
  2. Gestion du poids et métabolisme
  3. SLU-PP-332 (100mg/capsule), 60 Capsules
Gestion du poids

SLU-PP-332 (100mg/capsule), 60 Capsules

SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes.

Conditionnement: SLU-PP-332 (100mg/capsule), 60 Capsules.

Conditionnement illustratif généré par IA.

Le prix initial était : 196,95 €.Le prix actuel est : 137,87 €.

Disponible sur demande en France

Demander à un conseiller
Un conseiller vous contacte et la pharmacie partenaire vérifie si et comment la demande peut aboutir. Une ordonnance valide, ou une évaluation par un service de télémédecine autorisé, peut être nécessaire.
  • Pharmacie partenaire
  • Accompagnement personnalisé
  • Livraison discrète
  • Conditionnement
    SLU-PP-332 (100mg/capsule), 60 Capsules

Expédition et livraison

  • Expédition habituellement sous 24 heures après confirmation du paiement.
  • USPS Regular Shipping · 11,95 € · Env. 3–5 jours ouvrés
  • FedEx 2 Days Delivery · 28,99 € · Env. 2 jours ouvrés
  • FedEx Overnight Delivery · 40,99 € · Env. 1 jour ouvré

Réservé à la recherche en laboratoire.

Ne pas utiliser chez l’être humain ou l’animal.

Composition et détails du produit

Présentation

SLU-PP-332 is a selective pan-estrogen receptor-related receptor (ERR) agonist with demonstrated activity across ERRα, ERRβ, and ERRγ subtypes. The compound exhibits properties related to enhanced mitochondrial biogenesis and oxidative phosphorylation in cellular models. Each unit contains 100mg of the active molecule, supplied in 60-count containers for research applications.

The compound is intended exclusively for analytical and laboratory research purposes.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Propriétés

Chemical Formula C18H14N2O2
Synonyms 4-Hydroxy-N’-(naphthalen-2-ylmethylene)benzohydrazide
Molar Mass 290.32 g/mol
CAS Number 303760-60-3
PubChem CID 5338394
Total Compound Content 6,000 mg (100 mg per capsule)
Shelf Life 36 months

Recherche

SLU-PP-332 is a synthetic pan-agonist of the estrogen-related receptor (ERR) subfamily, exhibiting activity across ERRα, ERRβ, and ERRγ receptor subtypes. These orphan nuclear receptors function as constitutively active transcription factors that regulate gene expression programs through interactions with coactivator proteins and transcriptional regulatory complexes. SLU-PP-332 has been characterized as a highly selective and potent pan-ERR agonist, making it a valuable research tool for investigating ERR receptor pharmacology, receptor-coactivator interactions, and nuclear receptor-mediated signaling pathways.

Résultats de laboratoire

Results refer to the tested sample. Check the batch and date in the report.

HPLC – SLU-PP-332 (3583)
September 24, 2026

FAQ

What are estrogen-related receptors (ERRs) and why is SLU-PP-332 significant as a pan-agonist?

ERRα, ERRβ, and ERRγ are orphan nuclear receptors that function as constitutively active transcription factors within the nuclear receptor superfamily. These receptors regulate gene expression through interactions with coactivator proteins and transcriptional regulatory complexes.

SLU-PP-332 is notable for exhibiting activity across all three ERR subtypes, making it a valuable research tool for investigating pan-ERR receptor pharmacology, receptor-coactivator interactions, and the coordinated regulation of ERR-dependent transcriptional signaling networks.

What makes SLU-PP-332 useful for ERR receptor research?

SLU-PP-332 possesses a highly selective pan-ERR activity profile, enabling experimental investigation of ERRα-, ERRβ-, and ERRγ-mediated signaling within a single molecular framework. This characteristic allows researchers to examine receptor activation mechanisms, coactivator recruitment processes, transcriptional control systems, and downstream regulatory pathways associated with ERR signaling.

Its well-characterized pharmacological profile has established it as an important tool for studies of orphan nuclear receptor biology.

How does SLU-PP-332 differ from other nuclear receptor agonists?

SLU-PP-332 selectively targets the estrogen-related receptor family, whereas many other nuclear receptor agonists act through distinct receptor systems with different signaling architectures and transcriptional regulatory mechanisms. This receptor specificity makes SLU-PP-332 useful for comparative investigations of nuclear receptor pharmacology, receptor-ligand interactions, coactivator biology, and the molecular processes governing receptor-mediated transcriptional regulation.

Les excipients de la gélule ne sont pas précisés dans la documentation disponible.

Le prix initial était : 196,95 €.Le prix actuel est : 137,87 €.